Johnson & Johnson has a chance to show it's more than just a rotation winner
The healthcare giant's second-quarter earnings will shine the spotlight on its exciting new products and pipeline.
The healthcare giant's second-quarter earnings will shine the spotlight on its exciting new products and pipeline. This story matters for Finance & Markets readers tracking fund. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. FundNews curates and briefs the finance & markets stories that matter. Our editorial policy →